Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Operating Expenses | 7,609 | 5,512 | 0 | 1,727 | 8,662 |
Operating Income | -7,609 | -5,512 | N/A | -1,727 | -8,662 |
Other Income | 381 | 150 | 0 | -9,421 | -11 |
Pre-tax Income | -7,228 | -5,362 | 0 | -11,148 | -8,673 |
Net Income Continuous | -7,228 | -5,362 | N/A | -11,148 | -8,673 |
Net Income | $-7,228 | $-5,362 | $N/A | $-11,148 | $-8,673 |
EPS Basic Total Ops | -2.21 | -31.90 | N/A | -89.66 | -94.86 |
EPS Basic Continuous Ops | -2.21 | -31.90 | N/A | -87.68 | -94.10 |
EPS Diluted Total Ops | -2.21 | -31.90 | N/A | -89.66 | -94.86 |
EPS Diluted Continuous Ops | -2.21 | -31.90 | N/A | -87.68 | -94.10 |
EBITDA(a) | $-7,609 | $-5,512 | $N/A | $-1,727 | $-8,662 |